SAMUEL MEADEMA, MD
Otolaryngology Physician in DANVILLE, Virginia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
SAMUEL MEADEMA, MD filed 2,535 Medicare Part D claims in 2023 as a Otolaryngology Physician in DANVILLE, Virginia, prescribing 98% generic.
- 3K
- Part D claims, 2023
- 98%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
SAMUEL MEADEMA, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
2,535 Top 13% higher than 87% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
SAMUEL MEADEMA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about SAMUEL MEADEMA, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Virginia
How Otolaryngology Physician compares to other specialties among Virginia providers
Otolaryngology Physician share within Virginia
Otolaryngology Physician is one of the more visible NUCC categories in Virginia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Otolaryngology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Otolaryngology Physician ABMS/AOA estimate
Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Otolaryngology Physician US NPIs
Specialty board-certified rate — Otolaryngology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
SAMUEL MEADEMA, MD appears in the CMS NPPES registry as a Otolaryngology Physician provider holding MD credentials at 159 EXECUTIVE DR, DANVILLE, VA, 24541, with a listed phone of (434) 792-0830. NPI 1649225764 was issued on 05/24/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MEADEMA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,535 prescription claims written by this provider, covering 610 Medicare beneficiaries and totaling roughly $61K in drug spend, split 2% brand-name and 98% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1649225764 |
|---|---|
| Specialty | Otolaryngology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/24/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm SAMUEL MEADEMA, MD's current license status, disciplinary history, and board certifications with the Virginia Board of Medicine in Virginia before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where SAMUEL MEADEMA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SAMUEL MEADEMA, MD. Source: openpaymentsdata.cms.gov.
Total received
$282
Largest payer
Regeneron Healthcare Solutions, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
2% brand-name claims vs 98% generic, on 2,535 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,027
- Total Day Supply
- 107,611
- Brand vs Generic
- 2% brand / 98% generic
- Brand Drug Cost
- $13K
- Generic Drug Cost
- $48K
- Antibiotic Claims
- 206
Patient Demographics
- Average Patient Age
- 72.3 years
- Avg HCC Risk Score
- 1.19
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 77, 65-74: 286, 75-84: 194, 85+: 53
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What SAMUEL MEADEMA, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levocetirizine Dih…
Levocetirizine Dihydrochloride
423 claims
- Pantoprazole Sodium
Pantoprazole Sodium
282 claims
- Omeprazole
Omeprazole
217 claims
- Azelastine Hcl 141
Azelastine Hcl
141 claims
- Levothyroxine Sodium 97
Levothyroxine Sodium
97 claims
- Amitriptyline Hcl 94
Amitriptyline Hcl
94 claims
- Montelukast Sodium 89
Montelukast Sodium
89 claims
- Diazepam 88
Diazepam
88 claims
| Drug | Claims |
|---|---|
| Levocetirizine Dihydrochloride | 423 |
| Pantoprazole Sodium | 282 |
| Omeprazole | 217 |
| Azelastine Hcl | 141 |
| Levothyroxine Sodium | 97 |
| Amitriptyline Hcl | 94 |
| Montelukast Sodium | 89 |
| Diazepam | 88 |
| Mometasone Furoate | 79 |
| Famotidine | 78 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngology Physician Overview
How SAMUEL MEADEMA, MD fits within the Otolaryngology Physician landscape nationally.
SAMUEL MEADEMA, MD's 2,535 claims are above the specialty average of 509.
Nearby Otolaryngology Physician Providers in Virginia
Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as MEADEMA.
Compare Otolaryngology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Virginia
Frequently Asked Questions
What is SAMUEL MEADEMA, MD's specialty? ▼
How much does SAMUEL MEADEMA, MD prescribe under Medicare Part D? ▼
Where is SAMUEL MEADEMA, MD located? ▼
What is SAMUEL MEADEMA, MD's NPI number? ▼
Does SAMUEL MEADEMA, MD prescribe more brand-name or generic drugs? ▼
How many Otolaryngology Physician providers are there in the US? ▼
What drugs does SAMUEL MEADEMA, MD prescribe most often? ▼
Does SAMUEL MEADEMA, MD accept Medicare? ▼
How can I verify SAMUEL MEADEMA, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology